Nucleocapsid protein (SARS-CoV-2) (N protein)

The SARS-CoV-2 nucleocapsid (N) protein is a highly conserved structural protein essential for the viral life cycle across the Betacoronavirus genus, including SARS-CoV and MERS-CoV. Its primary biological function involves binding to the viral RNA genome to form a helical ribonucleoprotein (RNP) complex, which is critical for genome packaging, viral assembly, and protecting the viral RNA (UniProt P0DTC9). Beyond its structural role, the N protein is a multifunctional phosphoprotein that modulates host cellular processes, such as inhibiting the host's interferon-mediated antiviral response and regulating viral RNA synthesis (PubMed: 32558601). In clinical practice, the N protein is the most abundant viral protein and serves as a primary biomarker for rapid antigen diagnostic tests and serological assays to detect past infections (CDC). While most first-generation vaccines target the Spike protein, the N protein is a key component in next-generation "universal" coronavirus vaccines because its high sequence conservation allows for broad T-cell mediated immunity against multiple variants (PubMed: 33807068). Therapeutic development focuses on small molecules that disrupt the N-terminal RNA-binding domain or the C-terminal dimerization domain, effectively halting viral replication by preventing RNP formation (PubMed: 34108476).

Other names

NucleoproteinN proteinSARS-CoV-2 NProtein NNCBetacoronavirus nucleocapsid

Inhibition of viral RNA binding and packaging, disruption of nucleocapsid dimerization, or induction of cellular immune responses through T-cell epitope presentation.